We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs, Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » Device Accessories – Understanding and Implementing the Final Guidance - Webinar CD/Transcript

Other Options

Audio CD/Transcript - March 23, 2017

$287.00

Audio CD/Transcript - March 23, 2017

$258.00

Audio CD/Transcript - March 23, 2017

$244.00

Audio CD/Transcript - March 23, 2017

$230.00

Audio CD/Transcript - March 23, 2017

$215.00

Device Accessories – Understanding and Implementing the Final Guidance - Webinar CD/Transcript

$287.00
Webinar Recordings

Product Details

Device Accessories – Understanding and Implementing the Final Guidance

Under the Food, Drug and Cosmetics Act (FD&CA) an accessory to a device is, itself, a device. But, it does not distinguish between accessories and other devices.

On Dec. 30, 2016, the FDA-CDRH+CBER issued a final guidance document to describe accessories and — in certain cases — provide a classification pathway.

The guidance describes and defines what the FDA considers an accessory with a three-prong performance determination including: to support, supplement or augment a parent device.

Dan O’Leary explains the approach in the guidance document and gives you the tools you need to determine and document whether any of your products are an accessory.

After this 90-minute session you’ll:

  • Learn the definition of an accessory and parent device from the guidance document — they are not in any regulations
  • Understand how the definition applies to “software as a medical device”
  • Understand the three prong approach to application of the accessory definition
  • Learn how to determine the classification status of an accessory
  • Understand the two methods of change applicable to a classified accessory
  • Understand the use of the de novo process for an unclassified accessory

BONUS: You’ll receive a worksheet to help apply the definitions and determine if the accessory is classified as well as a copy of the guidance document.

Order today and learn to apply the guidance document to your products to determine if any of them are an accessory and ensure they meet device regulations.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing